NCT02980263View on ClinicalTrials.gov

Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 15, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Kawasaki Disease
Interventions
DRUG

Canakinumab

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY